# Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema

> **NCT02506530** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 93 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **PROCEDURE:** intensive decongestive treatment
- **DEVICE:** Cellu M6

## Key facts

- **NCT ID:** NCT02506530
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506530, "Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02506530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*